Company / Current Assets per Share
BIOCRYST PHARMACEUTICALS INC Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$1.85
FY2025
5-year range
$1.85 / $3.16
FY2021-FY2025
Trend
-9.4%
vs FY2024
Sector context
#178 of 210
Health Care
What the data says
BIOCRYST PHARMACEUTICALS INC's current assets per share of $1.85 is lower than 85% of companies in the Health Care sector (FY2025). Current Assets per Share has declined for 4 consecutive years, from $3.16 in FY2021 to $1.85 in FY2025.
Based on SEC 10-K filings.
1.85 in FY2025 with a 5-year CAGR of -0.9%.
Declined from $2.58 to $1.85 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -12.7%
- 5-Year CAGR
- -0.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 210This company $1.85 Sector average $134.38
▼
-98.6% below sector average
Key checks
Key Insights
- BIOCRYST PHARMACEUTICALS INC's current assets per share has declined for 4 consecutive years.
- In FY2025, current assets per share decreased 9.4% year-over-year.
- Ranks #178 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.85 | -9.4% |
| FY2024 | $2.04 | -20.9% |
| FY2023 | $2.58 | -7.1% |
| FY2022 | $2.78 | -12.1% |
| FY2021 | $3.16 | +63.3% |
| FY2020 | $1.94 | +36.2% |
| FY2019 | $1.42 | +28.3% |
| FY2018 | $1.11 | -34.8% |
| FY2017 | $1.70 | +86.1% |
| FY2016 | $0.91 | +3.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026